1. Cometriq (cabozantinib)
    Cometriq (cabozantinib)
    by Ipsen Pharma
    for Thyroid Cancer
  2. Cotellic (cobimetinib)
    Cotellic (cobimetinib)
    by Roche Registration GmbH
    for Skin Cancer
  3. Darzalex (daratumumab)
    Darzalex (daratumumab)
    by Janssen-Cilag International N.V.
    for Multiple Myeloma
  4. Empliciti (elotuzumab)
    Empliciti (elotuzumab)
    by Bristol-Myers Squibb
    for Multiple Myeloma
  5. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
  6. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
  7. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
  8. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
  9. Lonsurf (trifluridine/tipiracil)
    Lonsurf (trifluridine/tipiracil)
    by Les Laboratoires Servier
    for Colorectal Cancer
View as Grid List

Items 19-27 of 39

per page
Set Descending Direction